Economist Proposes €2,000 Deductible for German Public Health Insurance: A Controversial Cost-Sharing Plan
The debate over how to fund Germany's public health insurance (Gesetzliche Krankenversicherung, GKV) is intensifying. Economist Professor Bernd Raffelhüschen has put forward a provocative proposal: introducing a significant annual deductible, capped at €2,000, for GKV patients. For American readers, this is akin to proposing a mandatory High-Deductible Health Plan (HDHP) structure for a system that currently functions more like a combination of Medicare and comprehensive employer insurance with very low out-of-pocket costs. This plan aims to curb soaring healthcare expenditures but faces fierce criticism over its potential impact on access and equity. Here’s a deep dive into the proposal, its evolution, the arguments for and against, and its likelihood of becoming reality.
The Proposal: A Tiered Annual Deductible Model
Raffelhüschen's plan has evolved. His latest iteration, as reported in June 2023, outlines a tiered cost-sharing system:
- First €800: Patients pay 100% of outpatient doctor costs (hospital surgeries excluded).
- €800 to €2,000: The health insurance fund covers 50% of costs; the patient pays the other 50%.
- Above €2,000: The insurance fund covers 100% of further costs for the year.
This is a modification from his original February 2023 proposal, which suggested patients pay the first €1,500-€2,000 in full. The new model provides earlier, albeit partial, support from the insurer.
Additional Controversial Elements:
- Risk-Based Surcharges: Smokers, obese individuals, and high-risk sports enthusiasts would face higher deductibles or co-pays for treatments related to their chosen risks.
- Billing Transparency: Patients would receive an invoice after each visit and submit it to their insurer for reimbursement, intended to increase cost awareness.
- State Subsidies for Low-Income Earners: The government would provide subsidies to help low-income individuals afford the deductible.
The Rationale: Combating a Financial Crisis
Raffelhüschen argues that without radical reform, the GKV system is financially unsustainable. His key points:
- Massive Deficits: The GKV ran a €28.5 billion deficit in 2022, which some projections suggest could nearly double by 2025.
- Rising Premiums: He warns that contribution rates could rise to 22% by 2035 from the current average of ~16.2% (14.6% base + ~1.6% supplementary).
- Reducing "Unnecessary" Care: The deductible is designed to make patients more cost-conscious, potentially reducing frivolous doctor visits and encouraging more efficient use of resources.
- Parallel Cost-Cutting: He also advocates reducing the number of hospitals by 30-40% to eliminate inefficiencies.
Criticism and Major Counterarguments
The proposal has been met with strong opposition from health policy experts, patient advocates, and politicians. Key criticisms include:
| Stakeholder Group | Potential Benefit | Potential Harm / Risk |
|---|---|---|
| Healthy, High-Income Individuals | Could benefit from lower long-term premium growth if system costs are controlled. | Minimal direct impact if they rarely see a doctor. |
| Low-Income & Chronically Ill | State subsidies might offset costs (but implementation is uncertain). | High financial burden; may delay necessary care, leading to worse health and higher costs later. Exacerbates health inequalities. |
| Seniors & Frequent Care Users | None apparent. | Would consistently pay the high deductible, facing a significant new annual financial burden. |
| The GKV System | Short-term reduction in outpatient claims volume and costs. | Long-term costs may rise due to delayed care; high administrative cost of managing subsidies and tiered reimbursements. |
Core Criticisms:
- Equity and Access: Health Minister Karl Lauterbach (SPD) dismissed it, stating, "For university professors... these proposals are affordable. For the vast majority of the population, this does not work." If the state must subsidize the deductible for most people, the net savings vanish.
- Historical Precedent: Germany's previous experiment with a €10 per-quarter "Praxisgebühr" (practice fee) from 2004-2012 showed a temporary drop in doctor visits, but usage returned to normal. Crucially, it deterred preventive care among low-income groups, potentially increasing long-term costs.
- Misdiagnosis of the Problem: Critics argue the GKV's deficit is driven primarily by demographics (an aging society) and macroeconomic factors, not by overuse of services by the healthy. A deductible does not address these root causes.
- Penalizing Lifestyle: Surcharges based on lifestyle are seen as punitive and ignore the complex socio-economic factors behind health behaviors.
Alternative Solutions on the Table
Other proposals to stabilize the GKV focus on systemic, rather than individual, cost-bearing:
- Reducing VAT on Medicines: Lowering the value-added tax on pharmaceuticals from 19% to 7%.
- State-Funded Premiums for Welfare Recipients: Having the government fully cover premiums for citizens receiving basic income support.
- Separating "Non-Insurance" Benefits: Financing items like maternity pay, sick pay for children, and free family coverage directly from the federal budget instead of through GKV contributions.
Proponents argue these measures could save the GKV tens of billions annually without creating barriers to care.
Conclusion: A Politically Unlikely but Defining Debate
While Bernd Raffelhüschen's €2,000 deductible proposal has ignited a necessary conversation about the sustainability of German public health insurance, its political prospects are dim. The current government firmly opposes it. However, the debate underscores the severe financial pressures on the GKV—pressures familiar to anyone following Medicare solvency discussions in the US. The ultimate solution will likely involve a mix of measures: controlling drug and hospital costs, exploring alternative financing, and improving efficiency. For now, the Raffelhüschen plan serves as a stark reminder of the difficult trade-offs between controlling healthcare costs, maintaining universal access to care, and ensuring the system's long-term financial health.